p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003.

MLA

Taylor, Lewis W., et al. “P-Tau Ser356 Is Associated with Alzheimer’s Disease Pathology and Is Lowered in Brain Slice Cultures Using the NUAK Inhibitor WZ4003.” Acta Neuropathologica, vol. 147, no. 1, Jan. 2024, p. 7. EBSCOhost, https://doi.org/10.1007/s00401-023-02667-w.

APA

Taylor, L. W., Simzer, E. M., Pimblett, C., Lacey-Solymar, O. T. T., McGeachan, R. I., Meftah, S., Rose, J. L., Spires-Jones, M. P., Holt, K., Catterson, J. H., Koch, H., Liaquat, I., Clarke, J. H., Skidmore, J., Smith, C., Booker, S. A., Brennan, P. M., Spires-Jones, T. L., & Durrant, C. S. (2024). p-tau Ser356 is associated with Alzheimer’s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003. Acta Neuropathologica, 147(1), 7. https://doi.org/10.1007/s00401-023-02667-w

Chicago

Taylor, Lewis W, Elizabeth M Simzer, Claire Pimblett, Oscar T T Lacey-Solymar, Robert I McGeachan, Soraya Meftah, Jamie L Rose, et al. 2024. “P-Tau Ser356 Is Associated with Alzheimer’s Disease Pathology and Is Lowered in Brain Slice Cultures Using the NUAK Inhibitor WZ4003.” Acta Neuropathologica 147 (1): 7. doi:10.1007/s00401-023-02667-w.